Unusual Facts
New allergy treatment
Single source · unconfirmed
Prepared by the Prisma AI-based automated newsroom · cross-checked against sources
American researchers have found that the medication omalizumab significantly reduces the severity of allergic reactions in people with alpha-gal syndrome. During treatment lasting an average of 23 months, nearly all patients reported a clinically significant reduction in the frequency or severity of allergic reactions. This may allow some patients to reintroduce red meat into their diet.
Sources: N+1 (Telegram) · N+1
🖼 AI illustration
Sources: N+1 (Telegram) · N+1
🖼 AI illustration
Prism: who is reporting · 2
Asia & othersN+1 (Telegram)N+1
⚑ Spotted an error?
✓ Thank you! The editors will check within 24 hours.